Table 2.
Protein C Percentiles |
||||||
---|---|---|---|---|---|---|
<20th | 20th–39th | 40th–59th | 60th–79th | ≥80th | P for trend | |
Range, μg/mL | <2.6 | 2.7–2.9 | 3.0–3.2 | 3.3–3.6 | ≥3.7 | |
No. at risk | 2,705 | 2,650 | 2,899 | 2,871 | 2,754 | |
No. of cases | 142 | 109 | 124 | 123 | 115 | |
Person-years of follow-up | 41,829 | 41,897 | 46,014 | 45,524 | 43,955 | |
Incidence rate/1000 person-years | 3.4 | 2.6 | 2.7 | 2.7 | 2.6 | |
Age-, race-, and sex-adjusted RR (95% CI) | 1.26 (0.98–1.61) | 0.99 (0.76–1.29) | 1.04 (0.80–1.34) | 1.02 (0.79–1.31) | 1.0 | 0.13 |
Multivariate-adjusted* RR (95% CI) | 1.38 (1.07–1.77) | 1.08 (0.83–1.41) | 1.13 (0.88–1.47) | 1.11 (0.86–1.44) | 1.0 | 0.03 |
Multivariate-adjusted† RR (95% CI) | 1.52 (1.17–1.98) | 1.18 (0.90–1.55) | 1.22 (0.94–1.58) | 1.16 (0.90–1.50) | 1.0 | 0.004 |
Adjusted for age, race-field center, sex, systolic blood pressure, use of antihypertensive medication, smoking status, diabetes mellitus, and education.
Further adjustment for LDL cholesterol, HDL cholesterol, fibrinogen, and von Willebrand factor.